Chiome Bioscience Inc. (TYO:4583)
Japan flag Japan · Delayed Price · Currency is JPY
76.00
+1.00 (1.33%)
Nov 18, 2026, 10:20 AM JST

Chiome Bioscience Cash Flow Statement

Millions JPY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-982.78-1,021-1,220-1,243-1,480
Depreciation & Amortization
3.741.171.21.482.96
Loss (Gain) From Sale of Investments
----150
Other Operating Activities
-0.37-32.467.05-1.0422.15
Change in Accounts Receivable
-20.9332.1332.02-89.7631.32
Change in Inventory
-3.2417.947.37-12.4930.21
Change in Accounts Payable
10.25-10.545.872.06-10.3
Change in Unearned Revenue
130.33---4.6-
Change in Other Net Operating Assets
-72.9811.8897.31156.22122.27
Operating Cash Flow
-935.99-1,001-1,069-1,191-1,131
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-40.08----
Sale of Property, Plant & Equipment
--0.17--
Other Investing Activities
-15.38----35.38
Investing Cash Flow
-55.46-0.17--35.38

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
--10713
Long-Term Debt Issued
200----
Total Debt Issued
200-10713
Short-Term Debt Repaid
-194.8-9.5---
Long-Term Debt Repaid
-25----
Total Debt Repaid
-219.8-9.5---
Net Debt Issued (Repaid)
-19.8-9.510713
Issuance of Common Stock
160.031,748560.31,126268.34
Repurchase of Common Stock
-7.03-0.58---
Other Financing Activities
-0-00-00
Financing Cash Flow
133.21,738667.31,127271.35

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Miscellaneous Cash Flow Adjustments
-0--0-
Net Cash Flow
-858.25737.73-401.72-63.72-895.33

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-976.07-1,001-1,069-1,191-1,131
Free Cash Flow Growth
-----
Free Cash Flow Margin
-164.52%-128.16%-156.67%-188.81%-158.68%
Free Cash Flow Per Share
-14.38-17.19-21.58-27.08-28.09
Levered Free Cash Flow
-641.7-651.57-630.68-748.1-648.68
Unlevered Free Cash Flow
-639.73-649.78-629.39-747.27-647.86

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
3.162.872.071.321.32
Cash Income Tax Paid
2.535.015.013.24-4.56
Change in Working Capital
43.4251.41142.5751.43173.5